Artisan Partners
NBIX icon

Artisan Partners’s Neurocrine Biosciences NBIX Stock Holding History

Artisan Partners’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-289,942
Closed -$26.1M – 306
2019
Q3 		$26.1M Buy
289,942
+14,745
+5% +$1.38M 0.05% 223
2019
Q2 		$23.2M Sell
275,197
-7,157
-3% -$588K 0.04% 230
2019
Q1 		$24.9M Sell
282,354
-1,389,833
-83% -$116M 0.05% 219
2018
Q4 		$119M Sell
1,672,187
-165,077
-9% -$15.8M 0.27% 85
2018
Q3 		$226M Sell
1,837,264
-40,381
-2% -$4.58M 0.43% 65
2018
Q2 		$184M Sell
1,877,645
-88,464
-4% -$7.92M 0.37% 78
2018
Q1 		$163M Buy
1,966,109
+657,712
+50% +$55.5M 0.33% 83
2017
Q4 		$102M Buy
1,308,397
+968,957
+285% +$66.1M 0.19% 126
2017
Q3 		$20.8M Sell
339,440
-7,975
-2% -$421K 0.04% 214
2017
Q2 		$16M Buy
+347,415
New +$16.9M 0.03% 219

Other funds holding NBIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Artisan Partners's NBIX Position: Q4 2019 in Review

Artisan Partners sold out of Neurocrine Biosciences (NBIX) in Q4 2019, closing a stake of 289,942 shares — an estimated $26.1M sold.

Artisan Partners first reported a position in NBIX in Q2 2017 and held it in 10 quarters. The position peaked at $226M in Q3 2018. 392 funds tracked by Wall St. Rank hold NBIX as of Q4 2019.

  • Artisan Partners reported no remaining Neurocrine Biosciences position as of Q4 2019 after selling out during the quarter.
  • Artisan Partners sold 289,942 Neurocrine Biosciences shares in Q4 2019, an estimated $26.1M.
  • Artisan Partners first reported a position in Neurocrine Biosciences in Q2 2017 and held it in 10 quarters.
  • Artisan Partners's Neurocrine Biosciences position peaked at $226M in Q3 2018.
  • 392 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q4 2019.

Based on Artisan Partners's 13F filing for Q4 2019, filed 12 Feb 2020.